“Long‐term Efficacy and Safety of Vedolizumab in Inflammatory Bowel Diseases Patients: A Real‐life Experience From a Tertiary Referral Center”
Journal of Digestive Diseases - Australia
doi 10.1111/1751-2980.12748
Full Text
Open PDFAbstract
Available in full text
Categories
Date
May 1, 2019
Authors
Publisher
Wiley